Regulation of IFNβ expression: focusing on the role of its promoter and transcription regulators.

Front Microbiol · 2023 · PMC10309559 · PMID 37396372

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Therefore, developing drugs that target the distal enhancer sequence or regulatory process may be significant for treating some diseases that involves overexpression of IFNβ.

also in 5,654 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.